Skip to main content
Fig. 2 | Advances in Rheumatology

Fig. 2

From: Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study

Fig. 2

A 12-Month follow-up regarding skin and gut disease activity over time (At baseline, visits at 3, 6 and 12 months). a Patients with psoriasis and psoriasis area and severity index (PASI) after therapeutic decision-making. b Patients with inflammatory bowel disease and daily diarrhea episodes after therapeutic decision-making

Back to article page

Advances in Rheumatology

ISSN: 2523-3106